pI: 9.4038 |
Length (AA): 273 |
MW (Da): 31094 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127120)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G51520 | diacylglycerol O-acyltransferase 2 |
Brugia malayi | Bm1_55350 | diacylglycerol acyltransferase family protein |
Candida albicans | CaO19.6941 | similar to diacylglycerol acyltransferase type 2B |
Candida albicans | CaO19.14203 | similar to diacylglycerol acyltransferase type 2B |
Caenorhabditis elegans | CELE_W01A11.2 | Protein DGTR-1 |
Caenorhabditis elegans | CELE_K07B1.4 | Protein K07B1.4, isoform A |
Caenorhabditis elegans | CELE_F59A1.10 | Protein DGAT-2 |
Cryptosporidium hominis | Chro.60038 | hypothetical protein |
Cryptosporidium parvum | cgd6_260 | hypothetical protein with 4 transmembrane domains |
Dictyostelium discoideum | DDB_G0290279 | diacylglycerol O-acyltransferase 2 |
Drosophila melanogaster | Dmel_CG1946 | CG1946 gene product from transcript CG1946-RA |
Drosophila melanogaster | Dmel_CG1941 | CG1941 gene product from transcript CG1941-RC |
Drosophila melanogaster | Dmel_CG1942 | CG1942 gene product from transcript CG1942-RA |
Homo sapiens | ENSG00000124003 | monoacylglycerol O-acyltransferase 1 |
Homo sapiens | ENSG00000062282 | diacylglycerol O-acyltransferase 2 |
Homo sapiens | 80168 | monoacylglycerol O-acyltransferase 2 |
Leishmania braziliensis | LbrM.25.2380 | diacylglycerol acyltransferase, putative |
Leishmania donovani | LdBPK_251690.1 | diacylglycerol acyltransferase, putative |
Leishmania infantum | LinJ.25.1690 | diacylglycerol acyltransferase, putative |
Leishmania major | LmjF.25.1630 | diacylglycerol acyltransferase, putative |
Leishmania mexicana | LmxM.25.1630 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_11576 | diacylglycerol acyltransferase |
Mus musculus | ENSMUSG00000052396 | monoacylglycerol O-acyltransferase 2 |
Mus musculus | 102632711 | 2-acylglycerol O-acyltransferase 2-A-like |
Mus musculus | ENSMUSG00000012187 | monoacylglycerol O-acyltransferase 1 |
Mus musculus | ENSMUSG00000030747 | diacylglycerol O-acyltransferase 2 |
Neospora caninum | NCLIV_046590 | Diacylglycerol acyl transferase, related |
Oryza sativa | 4340911 | Os06g0326700 |
Oryza sativa | 4330511 | Os02g0714100 |
Onchocerca volvulus | OVOC7310 |
|
Saccharomyces cerevisiae | YOR245C | diacylglycerol O-acyltransferase |
Schistosoma japonicum | Sjp_0053250 | 2-acylglycerol O-acyltransferase 2-A, putative |
Schistosoma japonicum | Sjp_0312950 | 2-acylglycerol O-acyltransferase 1, putative |
Schistosoma mansoni | Smp_158510 | diacylglycerol O-acyltransferase 1 |
Schmidtea mediterranea | mk4.011671.01 | |
Schmidtea mediterranea | mk4.021164.04 | |
Schmidtea mediterranea | mk4.012113.03 | |
Schmidtea mediterranea | mk4.019233.00 | |
Trypanosoma brucei gambiense | Tbg972.3.1540 | diacylglycerol acyltransferase, putative |
Trypanosoma brucei | Tb927.3.1700 | diacylglycerol acyltransferase, putative |
Trypanosoma congolense | TcIL3000_3_790 | diacylglycerol acyltransferase, putative |
Trypanosoma cruzi | TcCLB.510421.260 | diacylglycerol acyltransferase, putative |
Trypanosoma cruzi | TcCLB.510089.219 | diacylglycerol acyltransferase, putative |
Toxoplasma gondii | TGME49_226370 | dgat2l1-prov protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.1700 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1700 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1700 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.1700 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_K07B1.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_W01A11.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_W01A11.2 | Caenorhabditis elegans | sterile | wormbase |
TGME49_226370 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | diacylglycerol O-acyltransferase 2 | Compounds | References |
Homo sapiens | monoacylglycerol O-acyltransferase 2 | Compounds | References |
Mus musculus | monoacylglycerol O-acyltransferase 2 | Compounds | References |